On July 13, 2022, Filament Health Corp (NEO:FH) closed its private placement of units ("Units") and convertible debenture units ("Convertible Debenture Units") for gross proceeds of C$2,500,080 (the “Offering”).
The Offering included a non-brokered private placement of 1,250 Convertible Debenture Units, issued at a price of C$1,000 per Convertible Debenture Unit, for gross proceeds of C$1,250,000. The Offering also included a non-brokered private placement of 9,616,000 Units, issued at a price of C$0.13 per Unit, for gross proceeds of C$1,250,080.
Filament is a natural psychedelic drug discovery and extraction technology company headquartered in Vancouver, British Columbia.
We acted on behalf of Filament with a team consisting of Shanlee von Vegesack (Corporate Finance and Securities), Marco Maduri (Corporate Finance and Securities), and Sabrina Chang (Articling Student).
Jurisdiction
- British Columbia
